Trends in use of benzodiazepines and Z-drugs in France from 2012 to 2020

Therapie. 2022 Dec 9;S0040-5957(22)00279-7. doi: 10.1016/j.therap.2022.12.005. Online ahead of print.

Authors

Anne Bénard-Laribière¹, Elodie Pambrun², Papa-Yatma Diop², Antoine Pariente³

Affiliations

¹ Université Bordeaux, Inserm, BPH, team Pharmacoepidemiology, U1219, 33000 Bordeaux, France. Electronic address: anne.benard@u-bordeaux.fr.
² Université Bordeaux, Inserm, BPH, team Pharmacoepidemiology, U1219, 33000 Bordeaux, France.
³ Université Bordeaux, Inserm, BPH, team Pharmacoepidemiology, U1219, 33000 Bordeaux, France; CHU de Bordeaux, Clinical Pharmacology Unit, 33000 Bordeaux, France.

PMID: 36586750
DOI: 10.1016/j.therap.2022.12.005

No abstract available

Keywords: Benzodiazepines; Drug utilization; Insurance health reimbursement; Pharmacoepidemiology.

Publication types

Letter